The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

iPSCs have been successfully used to treat age-related macular degeneration (AMD), a form of blindness. This disorder is caused by the loss of retinal pigment epithelium (RPE) due to aging. Skin cells from an AMD patient were isolated and reprogrammed to form iPSCs, which were then differentiated into RPE cells. When these newly formed RPE cells were transplanted into the patient's retina, they restored the patient's vision.

iPSCs have shown potential for treating sickle cell anemia using a patient's own cells. Researchers reprogrammed the bone marrow stromal cells of a sickle cell anemia patient to form iPSCs. The mutation that causes the sickle cell phenotype in iPSCs was corrected using the CRISPR-Cas system. These iPSCs, when differentiated into erythroid cells, expressed the normal β-globin protein.

iPSC-derived cells are also being explored for their potential in cancer therapy. Tissues destroyed in a cancer patient due to radiation or chemotherapy can be replaced using cells differentiated from the patient's cells. However, attempts to transplant such iPSC-derived cells have not to date been successful.

タグ
IPS CellsInduced Pluripotent Stem CellsCell DifferentiationRegenerative MedicineBlood CellsHepatocytesBeta Islet CellsCardiomyocytesNeuronsAge related Macular DegenerationRetinal Pigment EpitheliumSickle Cell AnemiaCRISPR Cas SystemCancer TherapyTissue Regeneration

章から 43:

article

Now Playing

43.6 : iPS Cell Differentiation

胚性幹細胞および人工多能性幹細胞

2.5K 閲覧数

article

43.1 : 胚性幹細胞

胚性幹細胞および人工多能性幹細胞

3.2K 閲覧数

article

43.2 : ES細胞の状態の維持

胚性幹細胞および人工多能性幹細胞

2.1K 閲覧数

article

43.3 : 人工多能性幹細胞

胚性幹細胞および人工多能性幹細胞

3.7K 閲覧数

article

43.4 : 体細胞からiPS細胞へのリプログラミング

胚性幹細胞および人工多能性幹細胞

2.1K 閲覧数

article

43.5 : iPS細胞におけるクロマチン修飾

胚性幹細胞および人工多能性幹細胞

1.6K 閲覧数

article

43.7 : 強制的な差別化転換

胚性幹細胞および人工多能性幹細胞

1.8K 閲覧数

article

43.8 : 疾患研究におけるEPS細胞とiPS細胞

胚性幹細胞および人工多能性幹細胞

2.7K 閲覧数

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved